Stock Price
4.44
Daily Change
0 0%
Monthly
13.85%
Yearly
74.12%
Q1 Forecast
4.10

Acasti Pharma reported $75K in Gross Profit on Sales for its fiscal quarter ending in March of 2021.





Gross Profit On Sales Change Date
Addus HomeCare USD 123.6M 6.89M Dec/2025
Amarin USD 22.21M 28.15M Sep/2025
Cassava Sciences USD -3.96M 1.16M Sep/2025
Knight Therapeutics CAD 55.81M 10.98M Sep/2025
Option Care Health USD 282.9M 10M Dec/2025
Organigram Holdings CAD 31.84M 23.88M Sep/2025
Tilray USD 67.63M 15.62M Mar/2025